Claims
- 1. A method of combating pathologically reduced cerebral functions and performance weaknesses, cerebral insufficiency and disorders in cerebral circulation and metabolism in warm-blooded animals which comprises administering to the said animals a cerebral specific effective amount for treating said conditions of 1,4dihydro-2,6dimethyl-4-(3'-nitrophenyl)-pyridino-3-(.beta.-methoxyethyl ester)-5-isopropyl ester either alone or in admixture with a diluent or in the form of a medicament.
- 2. A method according to claim 1 in which the active compound is administered intravenously in an amount of 0.0001 to 0.5 mg per kg body weight per day, or enterally in an amount of 0.001 to 1 mg per kg body weight per day.
- 3. A method according to claim 1, in which the compound is administered intravenously in an amount of 0.001 to 0.1 mg per kg body weight per day, or enterally in an amount of 0.01 to 0.5 mg per kg body weight per day.
- 4. A method according to claim 1 or 2 in which the active compound is administered orally.
Priority Claims (1)
Number |
Date |
Country |
Kind |
2815578 |
Apr 1978 |
DEX |
|
Parent Case Info
This is a continuation of application Ser. No. 027,540 filed Apr. 5, 1979 now abandoned.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
3799934 |
Meyer et al. |
Mar 1974 |
|
Non-Patent Literature Citations (1)
Entry |
Chem. Abst., vol. 78-1603G (1973). |
Continuations (1)
|
Number |
Date |
Country |
Parent |
27540 |
Apr 1979 |
|